Header Logo

Connection

KHALED YASSINE to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications KHALED YASSINE has written about Antibodies, Bispecific.
KHALED YASSINE
Connection Strength
0.213
Antibodies, Bispecific
  1. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 Feb; 30(2):217-227.
    View in: PubMed
    Score: 0.213
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.